NEW YORK (GenomeWeb News) – Rosetta Genomics will work with the Rabin Medical Center in Israel to develop microRNA-based tests for women’s health, the company said today.
 
The company plans to use microRNA biomarkers to develop “a wide range of diagnostic and prognostic tests” in oncology, gynecology, and obstetrics, the Rehovot, Israel-based company said.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.